Advaxis, Inc. announced the appointment of Molly Henderson as Executive Vice President and Chief Financial Officer, effective June 6, 2018. Ms. Henderson joins Advaxis from Cedar Cliff, LLC, where she served as a financial and business consultant to high-growth entrepreneurial companies. Previously she was Chief Financial Officer at Iovance Biotherapeutics, Inc.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.23 USD | +4.55% | +4.55% | -65.52% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-65.52% | 9.38M | |
+64.28% | 62.59B | |
-1.08% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.41% | 26.21B | |
-21.53% | 19.09B | |
+4.91% | 13.08B | |
+25.72% | 12.26B | |
+28.81% | 12.05B |
- Stock Market
- Equities
- ADXS Stock
- News Ayala Pharmaceuticals, Inc.
- Advaxis, Inc. Appoints Molly Henderson as Executive Vice President and Chief Financial Officer